Organic compounds -- part of the class 532-570 series patents - Monitor Patents
Fresh Patents
Monitor Patents Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations




USPTO Class 536  |  Browse by Industry: Previous - Next | All     monitor keywords
07/2008 | Recent  |  09: Oct | Sept | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan |  | 08: Dec | Nov | Oct | Sp | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan |  | 07: Dec  | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan |  | 06: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | 

Organic compounds -- part of the class 532-570 series inventions 07/08

Recently published patent applications awaiting approval from the USPTO. Recent week's RSS XML file available below.
Listing format for abstract view: USPTO application #, Title, Abstract excerpt,Patent Agent. Listing format for list view: USPTO National Class full category number, title of the patent application.
  
07/31/2008 > patent applications in patent subcategories.

20080182980 - Reactive functional groups: The present invention relates to compositions and methods for the preparation of modified nucleic acids. In particular, the present invention provides novel reagents and chemistries for the generation of linkers and modified phosphoramidates.... Agent: Casimir Jones, S.c.

20080182981 - Method and medicament for inhibiting the expression of a given gene: The invention relates to an isolated RNA that mediates RNA interference of an mRNA to which it corresponds and a method of mediating RNA interference of mRNA of a gene in a cell or organism using the isolated RNA.... Agent: Lowrie, Lando & Anastasi, LLP A2038

20080182982 - Methyl esters of hyaluronic acid: e

20080182983 - Hyaluronic acid oligosaccharide fractions and drugs containing the same: Hyaluronic acid oligosaccharides having a size selected from sizes of 4 to 60 saccharides, fractions containing the hyaluronic acid oligosaccharides and having particular physicochemical properties, and drugs containing the same. The hyaluronic acid oligosaccharides of the present invention are extremely useful, because they exert superior pharmaceutical effects as active ingredients... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

  
07/24/2008 > patent applications in patent subcategories.

20080177049 - Process for producing 1,2-trans-glycoside compound: wherein R2 and R3 are the same or different and are each alkyl having 1 to 4 carbon atoms or aryl having or not having a substituent, or R2 and R3 are combined to form alkylene having 2 to 4 carbon atoms (the alkylene may be substituted with alkyl having... Agent: Kubovcik & Kubovcik

20080177050 - Alpha, omega-difunctional aldaramides: Alpha, omega-difunctional aldaramides, in particular diaminoaldaramides, dihydroxyaldaramides, bis(alkoxycarbonylalkyl)aldaramides, and bis(carboxyalkyl)aldaramides, and processes for preparing the aldaramides are provided.... Agent: E I Du Pont De Nemours And Company Legal Patent Records Center

20080177052 - Corn event das-59122-7 and methods for detection thereof: The invention provides DNA compositions that relate to transgenic insect resistant maize plants. Also provided are assays for detecting the presence of the maize DAS-59122-7 event based on the DNA sequence of the recombinant construct inserted into the maize genome and the DNA sequences flanking the insertion site. Kits and... Agent: Pioneer Hi-bred International, Inc.

20080177051 - Sirna targeting cyclin-dependent kinase inhibitor 1b (p27, kip1) (cdkn1b): Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP

20080177053 - Dna nanocage by self-organization of dna and process for producing the same, and dna nanotube and molecule carrier using the same: The invention provides a process for producing DNA nanocages, characterized by comprising a step of two-dimensionally assembling three types of oligonucleotides by hybridization to form tridirectionally branched double-strand DNA having self-complementary chains in the terminals, and a step of three-dimensionally self-organizing the resulting tridirectionally branched double-strand DNAs so as to... Agent: Buchanan, Ingersoll & Rooney Pc

20080177054 - Automated parallel oligonucleotide synthesis: The invention is a system and method for the automated synthesis of biopolymers, such as polynucleotides. The synthesis reactions are conducted asynchronously in separate reaction volumes to minimize idle times for the machinery and to allow shorter polynucleotides to be removed when complete, rather than at the end of the... Agent: Philip S. Johnson Johnson & Johnson

20080177055 - Methods for preparing 2-alkynyladenosine deriviatives: e

20080177056 - Method for producing cellulose acylate film and cellulose acylate pellet: Provided is a cellulose acylate film formed through melt casting that is capable of being built in liquid-crystal display devices to solve the display trouble at the time of black level of display. That is a cellulose acylate film formed through melt casting, in which the number of polarizing minor... Agent: Buchanan, Ingersoll & Rooney Pc

20080177057 - Superabsorbent surface-treated carboxyalkylated polysaccharides and process for producing same: Surface-treated carboxyalkylated polysaccharides comprising a biobased content of at least 82% are described herein. The surface-treated carboxyalkylated polysaccharides comprise a CRC of at least 18 g/g, a FSC of at least 26 g/g, and an AUL at 0.7 psi of at least 14 g/g. Processes for the manufacture of surface-treated... Agent:

20080177058 - Saccharide fluorescence labeling method and saccharide fluorescence labeling apparatus: In one embodiment of the present invention, a first test tube including therein a dehydrated sample containing a sugar chain and a labeling agent solution made of 2-aminopyridine/acetic acid are stored in a well-closed container with the first test tube and the labeling agent solution secluded from each other. The... Agent: Harness, Dickey & Pierce, P.L.C

  
07/17/2008 > patent applications in patent subcategories.

20080171859 - 2'-arabino-fluorooligonucleotide n3'-p5' phosphoramidates: their synthesis and use: Oligonucleotides with a novel sugar-phosphate backbone containing at least one 2′-arabino-fluoronucleoside and an internucleoside 3′-NH—P(═O)(OR)—O-5′ linkage, where R is a positively charged counter ion or hydrogen, and methods of synthesizing and using the inventive oligonucleotides are provided. The inventive phosphoramidate 2′-arabino-fluorooligonucleotides have a high RNA binding affinity to complementary nucleic... Agent: Geron Corporation

20080171860 - Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation: The preparation and use of nucleic acid fragments encoding plant fatty acid modifying enzymes associated with conjugated double bond formation or functionally equivalent subfragments thereof are disclosed. Chimeric genes incorporating such nucleic acid fragments or functionally equivalent subfragments thereof or complement thereof and suitable regulatory sequences can be used to... Agent: E I Du Pont De Nemours And Company Legal Patent Records Center

20080171861 - Method and medicament for inhibiting the expression of a given gene: The invention relates to an isolated RNA that mediates RNA interference of an mRNA to which it corresponds and a method of mediating RNA interference of mRNA of a gene in a cell or organism using the isolated RNA.... Agent: Lowrie, Lando & Anastasi, LLP A2038

20080171862 - Method and medicament for inhibiting the expression of a given gene: The invention relates to an isolated RNA that mediates RNA interference of an mRNA to which it corresponds and a method of mediating RNA interference of mRNA of a gene in a cell or organism using the isolated RNA.... Agent: Lowrie, Lando & Anastasi, LLP A2038

20080171863 - Method for preparing of organofluoro compounds in alcohol solvents: The present invention relates to a method for preparation of organofluoro compounds containing radioactive isotope fluorine-18. More particularly, the present invention relates to a method for preparation of organofluoro compound by reacting fluorine salt containing radioactive isotope fluorine-18 with alkyl halide or alkyl sulfonate in the presence of alcohol of... Agent: Lucas & Mercanti, LLP

  
07/10/2008 > patent applications in patent subcategories.

20080167455 - Corn event das-59122-7 and methods for detection thereof: The invention provides DNA compositions that relate to transgenic insect resistant maize plants. Also provided are assays for detecting the presence of the maize DAS-59122-7 event based on the DNA sequence of the recombinant construct inserted into the maize genome and the DNA sequences flanking the insertion site. Kits and... Agent: Pioneer Hi-bred International, Inc.

20080167456 - Corn event mir604: A novel transgenic corn event designated MIR604, is disclosed. The invention relates to DNA sequences of the recombinant constructs inserted into the corn genome and of genomic sequences flanking the insertion site that resulted in the MIR604 event. The invention further relates to assays for detecting the presence of the... Agent: Syngenta Biotechnology, Inc. Patent Department

20080167454 - Nucleic acid-engineered materials: The present invention relates to the design and use of nucleic acid molecules to create novel materials. The present invention further related to the use of DNA as building block for DNA-materials that are of high yield and purity and that can be incorporated into larger structures.... Agent: Wilson Sonsini Goodrich & Rosati

20080167457 - Nonhuman model animal lacking the ability to control lymphocyte migration: The present invention provides a animal model useful in identifying a molecule controlling in a lymphocyte-specific manner migration and thus elucidating immune-related diseases and pathogenic conditions such as allergy, autoimmune diseases, GvH and graft rejections at a molecular level, or in developing a novel therapy. A nonhuman animal model such... Agent: Frommer Lawrence & Haug

20080167458 - Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same: The present invention relates to antibodies that bind CD33. More particularly, the invention relates to anti-CD33 antibodies, fragments and homologues of these antibodies, humanized and resurfaced versions of these antibodies, functional equivalents and improved versions of these antibodies, immunoconjugates and compositions comprising these antibodies, and the uses of same in... Agent: Sughrue Mion, PLLC

20080167459 - Amidite for nucleic acid synthesis and nucleic acid synthesizing method: where X denotes a base; Y denotes a protective group formed of any one of a 4-aminobutyric acid derivative, an o-aminomethylbenzoic acid derivative, an o-aminophenylacetic acid derivative, an o-aminoethylbenzoic acid derivative, an o-aminomethylphenylacetic acid derivative, an o-aminophenylpropionic acid derivative and a 5-aminovaleric acid derivative; and Q denotes one of a... Agent: Kratz, Quintos & Hanson, LLP

20080167460 - Separating agent for optical isomers, method of production thereof, and separation column for optical isomers: The present invention provides a separating agent for optical isomers having a porous monolithic inorganic type carrier and polysaccharide or a derivative thereof supported on the monolithic inorganic type carrier, and a separation column for optical isomers in which the separating agent for optical isomers is held in a column... Agent: Birch Stewart Kolasch & Birch

  
07/03/2008 > patent applications in patent subcategories.

20080161546 - Glycomimetic replacements for hexoses and n-acetyl hexosamines: Compounds and methods are provided for obtaining oligosaccharide mimics. More specifically, compounds and methods are described wherein oligosaccharide mimics are obtained by incorporating or substituting in a cyclohexane derivative.... Agent: Seed Intellectual Property Law Group Pllc

20080161547 - Sirna targeting serine/threonine protein kinase akt: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP

20080161548 - Compounds and methods for synthesis and purification of oligonucleotides: The present invention provides methods of extending nucleic acids and purifying target nucleic acids. The methods include the use of capping reagents to effect chain termination and provide a handle for purification via fluorous affinity methods.... Agent: Townsend And Townsend And Crew, LLP

20080161549 - Method of purifying nucleic acid molecules using proteinase k: The present invention provides methods for purifying nucleic acid molecules, wherein each method includes the steps of: (a) synthesizing nucleic acid molecules in a reaction mixture; (b) contacting the nucleic acid molecules with a proteinase for a period of time sufficient to degrade protein in the reaction mixture; (c) applying... Agent: Christensen, O'connor, Johnson, Kindness, Pllc

20080161550 - Process for the preparation of 4'-azido cytidine derivatives: e

20080161551 - Carrageenan based antimicrobial compositions: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more carrageenans, including lambda carrageenan. Also disclosed are methods for making and using the compositions.... Agent: Patent Administrator Fmc Corporation

20080161552 - Method for crystallizing sucralose: The present application discloses a method for crystallizing sucralose, which comprises using a mixed solvent, which comprises two solvents with different boiling points, wherein the solvent with lower boiling point has higher solubility to sucralose than the solvent with higher boiling point. The method of the present invention has the... Agent: Occhiuti Rohlicek & Tsao, LLP

20080161553 - Micro channel, device for recovering nucleic acid and method for recovering nucleic acid: A micro channel for recovering nucleic acid from a biological sample treated with a chaptropic ion, include an integrated portion composed of silica micro beads having a pore size of from 6 to 29 nm is formed in the channel.... Agent: Bell, Boyd & Lloyd, LLP

Previous industry: Organic compounds -- part of the class 532-570 series
Next industry: Organic compounds -- part of the class 532-570 series


######

RSS FEED for 20091126: - PDF
Integrate FreshPatents.com into your RSS reader/aggregator or website to track weekly updates.
For more info, read this article.

######

Thank you for viewing Organic compounds -- part of the class 532-570 series patents on the FreshPatents.com website. These are patent applications which have been filed in the United States. There are a variety ways to browse Organic compounds -- part of the class 532-570 series patent applications on our website including browsing by date, agent, inventor, and industry. If you are interested in receiving occasional emails regarding Organic compounds -- part of the class 532-570 series patents we recommend signing up for free keyword monitoring by email.



###

FreshPatents.com Support

Results in 0.25894 seconds

filepatents (1K)

* Easy, fast online form
* Protect your Inventions
* US Patent Office filing

Provisional Patent
Utility Patent

- - - - - - - - - - - - - - - - - - - - - -

filetrademarks (1K)

* Fast online form
* Protect your Name/Design
* US Government filing

Trademark Services

- - - - - - - - - - - - - - - - - - - - - -

PATENT INFO